SHR-1921

DRUG2 trials

Sponsors

Atridia Pty Ltd., Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Advanced Solid TumorOvarian Cancer

Phase 1

A Trial of SHR-A1921 for Injection in Subjects With Advanced Solid Tumors

CompletedNCT05594875

Atridia Pty Ltd.Advanced Solid Tumor

Start: 2022-12-01End: 2024-04-24Updated: 2024-06-25

Phase 2

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Not yet recruitingNCT06211023

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Ovarian Cancer

Start: 2024-02-15End: 2026-06-15Target: 520Updated: 2024-01-18